Celularity CEO RSUs vest, shares withheld for taxes
Celularity Inc Chief Executive Officer Robert J. Hariri reported routine equity compensation activity involving restricted stock units (RSUs).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Celularity Inc Chief Executive Officer Robert J. Hariri reported routine equity compensation activity involving restricted stock units (RSUs). On April 13, 2026, 3,281 RSUs granted on April 13, 2022 vested and converted into 3,281 shares of Class A Common Stock, representing 25% of a 13,123-RSU award.
To cover tax obligations on this vesting, 1,182 shares of Class A Common Stock were withheld at $1.28 per share, a non–open-market disposition. Following these transactions, Hariri directly holds 2,853,553 shares of Celularity Class A Common Stock.
Insider Trade Summary
3,281 shares exercised/converted
Exercise
3 txns
Insider
Hariri Robert J
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 3,281 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 3,281 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Class A Common Stock | 1,182 | $1.28 | $2K |
Holdings After Transaction:
Restricted Stock Units — 0 contracts (Direct);
Class A Common Stock — 2,853,553 shares (Direct)
Footnotes (4)
- F1. Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.
- F2. This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026.
- F3. Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.
- F4. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.
Key Figures
RSUs vested: 3,281 units
Original RSU grant: 13,123 units
Vesting percentage: 25%
+3 more
6 metrics
RSUs vested
3,281 units
Portion of 13,123-RSU grant vested on April 13, 2026
Original RSU grant
13,123 units
RSUs granted on April 13, 2022
Vesting percentage
25%
Portion of April 13, 2022 RSU grant that vested on April 13, 2026
Shares withheld for taxes
1,182 shares
Class A Common Stock withheld on RSU vesting
Tax withholding price
$1.28 per share
Valuation used for 1,182 withheld shares
Shares after transactions
2,853,553 shares
CEO’s direct Class A holdings following RSU vesting and tax withholding
Key Terms
Restricted Stock Units, tax withholding, economic equivalent, Form 4
4 terms
Restricted Stock Units financial
"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding financial
"This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026."
Tax withholding is the practice of taking a portion of a payment—such as wages, dividends, or sale proceeds—before it reaches the recipient and sending that portion to the tax authority as an advance on the recipient’s eventual tax bill. For investors it matters because withholding reduces immediate cash received and affects after‑tax returns, estimated tax payments, and whether you may owe more or receive a refund when taxes are finally calculated, like having a small automatic savings set aside for your tax bill.
economic equivalent financial
"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."
Form 4 regulatory
"The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Celularity (CELU) report for its CEO?
Celularity reported that CEO Robert J. Hariri had 3,281 restricted stock units vest and convert into 3,281 Class A shares. These RSUs are part of a prior equity grant and represent routine compensation rather than an open-market stock purchase or sale.
How many Celularity (CELU) RSUs vested for the CEO and from which grant?
3,281 RSUs vested for CEO Robert J. Hariri from a 13,123-RSU grant awarded on April 13, 2022. The filing states this vesting equals 25% of that original grant, with the vested RSUs converting on April 13, 2026 into an equal number of Class A shares.
What is the relationship between Celularity (CELU) RSUs and Class A Common Stock?
Each Celularity restricted stock unit is described as the economic equivalent of one share of Class A Common Stock. Upon vesting, RSUs convert into the same number of Class A shares, as shown when 3,281 RSUs vested and converted into 3,281 Class A Common Stock shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates